Business
BioSpectrum Asia
AstraZeneca inks collaboration worth $3.6 B with CSPC Pharma in China
AstraZeneca has entered a strategic research collaboration with Shijiazhuang City-based CSPC Pharmaceuticals Group.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
"By removing structural dependence, we unlock the full potential of AI for drug discovery"
Gero, a Singapore-based biotech company focused on aging and chronic diseases, launched ProtoBind-Diff, an AI model that generates small molecules for specific protein targets—using only the amino acid sequence, without needing 3D structural data.
5 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
MarkHerz signs MoU with German university hospital for research on next-generation gene therapies
MarkHerz Inc., a South Korea-based biotechnology startup specialising in AAV-based gene therapies targeting cardiovascular and metabolic diseases, has signed a Memorandum of Understanding (MoU) with Klinikum rechts der Isar, the university hospital affiliated with the Technical University of Munich (TUM), Germany.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
WHO issues first global guideline to improve pregnancy care for women with sickle cell disease
The World Health Organization (WHO) has released its firstever global guideline on the management of sickle cell disease (SCD) during pregnancy, addressing a critical and growing health challenge that can have life-threatening consequences for both women and babies. Health risks associated with SCD intensify during pregnancy, due to heightened demands on the body's oxygen and nutrient supply.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Sun Pharma names Kirti Ganorkar as new Managing Director
Sun Pharmaceutical Industries, based in India, has announced the appointment of Kirti Ganorkar as the Managing Director (MD) to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting to him.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Waters enhances Alliance iS HPLC System software
Waters Corporation has announced the release of version 2.0 of the Alliance iS HPLC System software, a significant advancement that provides full end-to-end traceability and enhanced data security for the pharmaceutical industry.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Vietnam Vaccine JSC injects $77 M in new manufacturing unit
Vietnam Vaccine Joint Stock Company (VNVC) has begun construction on its 26,000 square meter factory building with an investment of VND2 trillion ($77.17 million).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
HekaBio teams up with Alfresa Holdings accelerating access to innovative therapies in Japan
HekaBio K.K. has announced the signing of a strategic partnership agreement with Alfresa Holdings Corporation, a leading pharmaceutical wholesaler group in Japan.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Eastern Caribbean launches project to strengthen pandemic preparedness
A landmark initiative to boost pandemic preparedness and response in the Eastern Caribbean has been launched in Castries, Saint Lucia, bringing renewed focus to building resilient, integrated health systems that can better detect and respond to future health threats.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
WHO outlines recommendations to protect infants against RSV
The World Health Organization (WHO) has published its first-ever position paper on immunisation products to protect infants against respiratory syncytial virus (RSV) - the leading cause of acute lower respiratory infections in children globally.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Australia develops AI tool to ensure colorectal cancer patients receive correct dose of chemotherapy
University of Melbourne and Western Health researchers in Australia have developed a new artificial intelligence (AI) tool to prevent cancer patients from receiving incorrect doses of chemotherapy.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Gene Solutions, Shenzhen USK Bioscience to establish next-gen sequencing lab in Southern China
Vietnam-based startup Gene Solutions and Shenzhen USK Bioscience Co. (USKBio), a molecular diagnostics startup in China, have entered a strategic partnership through a Memorandum of Understanding (MoU).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
“Many US-based firms are actively seeking new opportunities in Asia for R&D partnerships, clinical trials, and commercialisation”
As Hong Kong accelerates its transformation into a global biotech and MedTech powerhouse, BioSpectrum Asia spoke with Andy Wong, Head of Innovation & Technology at Invest Hong Kong (InvestHK), at BIO International in Boston. Wong discussed increasing American interest in Hong Kong's innovation landscape, spotlighted promising local companies, and shared insights on how strategic partnerships, robust policy frameworks, and cross-border collaborations with Mainland China are positioning Hong Kong as a vital bridge between Western innovators and Asia’s thriving biotech ecosystem. Edited excerpts;
4 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Samsung Biologics launches drug screening services, Samsung Organoids
South Korea-based Samsung Biologics, a leading contract development and manufacturing organisation (CDMO), has announced the launch of Samsung Organoids, advanced drug screening services to support clients in drug discovery and development.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Singapore leads S$10 M national effort to tackle muscle-loss due to ageing
To tackle the growing threat of muscle loss in Singapore's ageing population, SingHealth Duke-NUS Academic Medical Centre will spearhead a S$10 million research initiative into sarcopenia, marking the country's first comprehensive, large-scale programme focused on this condition marked by loss of muscle mass and strength.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Serum Institute of India partners with DNDi to advance development of new dengue treatment
Serum Institute of India (SII), a part of Cyrus Poonawalla Group, and the not-for-profit medical research organisation Drugs for Neglected Diseases initiative (DNDi) have signed a Memorandum of Understanding (MoU) to accelerate the clinical development of a monoclonal antibody treatment for dengue that will be affordable and accessible in low- and middle-income countries (LMICs).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
India opens computing facility to boost genomic research
The Indian Council of Medical Research (ICMR), under the Health Ministry, has marked a significant milestone in advancing India's public health research capabilities with the inauguration of its first High Performance Computing (HPC) facility at the ICMR-National Institute of Virology (NIV), Pune.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
UK to boost clinical trials under 10 Year Health Plan
Patients will receive the most cutting-edge treatments years earlier than planned under the government's 10 Year Health Plan, which will speed up clinical trials so the UK becomes a hotbed of innovation.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
India discovers novel nanozyme to prevent excess blood clotting
Researchers at the Indian Institute of Science (IISc), Bengaluru have developed an artificial metal-based nanozyme that can potentially be used to clamp down on abnormal blood clotting caused by conditions like pulmonary thromboembolism (PTE).
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Korea focuses on exercise-induced protein to revive ageing muscles and bones
A joint research team, at the Korea Research Institute of Bioscience and Biotechnology and Chonnam National University, South Korea, has discovered a key protein, CLCF1 (cardiotrophinlike cytokine factor 1), that plays a central role in mediating the health benefits of physical activity.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Singapore designs new biomaterial to show how ageing in heart could be reversed
A new lab-grown material has revealed that some of the effects of ageing in the heart may be slowed and even reversed.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Royal Society elects Duke-NUS' Prof. Wong Tien Yin for Fellowship
Recognised for his invaluable contributions to science and innovation, Professor Wong Tien Yin from Singapore-based Duke-NUS' Office of Academic Medicine has been elected to the Fellowship of the Royal Society, the UK's national academy of sciences.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Riding High on China & India Diabetes, Obesity Surge
Semaglutide, a drug used for diabetes and weight management, is produced by Novo Nordisk and sold under the brand names Ozempic and Rybelsus for type 2 diabetes, and Wegovy for weight management.
2 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Why AI-Enabled ‘Dirty Drugs’ are Future for Longevity Medicine
Ageing is not a result of a single malfunction; it’s a gradual, systemic breakdown that touches everything. Researchers have long understood this and have mapped the tangled web of genes, pathways, enzymes, and signalling molecules involved. For decades, the pharmaceutical industry tried to simplify its way through the complexity of ageing. But now, with AI and polypharmacology, we finally have the tools to meet that complexity on its terms.
5 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
GenepoweRx and MGI Tech to accelerate AI-driven genomic solutions in personalised medicine
Indian startup GenepoweRx, a trailblazer in artificial intelligence (AI)-powered personalised medicine based on genomic insights, has announced a strategic collaboration with China-based MGI Tech Co.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Sanofi to accelerate development of new global vaccines in Abu Dhabi
The Department of Health - Abu Dhabi (DOH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MOU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
CEPI signs new agreement with US Dept of Defense focusing on disease outbreaks
Norway-based Coalition for Epidemic Preparedness Innovations (CEPI) and the US Department of Defense, Joint Programme Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND), have signed a new agreement that will enable the two organisations to collaborate on projects that expand global defences against disease outbreaks.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Sun Pharma names Kirti Ganorkar as new Managing Director
Sun Pharmaceutical Industries, based in India, has announced the appointment of Kirti Ganorkar as the Managing Director (MD) to succeed Dilip Shanghvi, effective September 1, 2025, with the entire business and all functions reporting to him.
1 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
IRREPLACEABLE HUMAN TOUCH
The trend of virtual and remote healthcare—including diagnostics and treatment—is gaining traction globally. Telemedicine, in particular, saw a rapid acceleration during COVID-19, when in-person consultations were often avoided due to the risk of virus transmission. Both healthcare providers and patients embraced remote care as a safer alternative. According to a GlobalData survey, 56 per cent of healthcare professionals believe that the growth of telemedicine and remote care has enhanced patients’ control over their health management. Among them, 13 per cent strongly agreed, while 26 per cent remained neutral. Only 2 per cent disagreed and 3 per cent strongly disagreed, showing widespread acceptance of this shift.
2 min |
BioSpectrum Asia July 2025
BioSpectrum Asia
Qiagen inks new partnership to develop oncology assays
Qiagen has announced a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed for clinical diagnostics.
1 min |